Consolidated Statements of Expenses (Unaudited) (USD $)	12 Months Ended		55 Months Ended
	Feb. 28, 2014	Feb. 28, 2013	Feb. 28, 2014
Revenue
Revenue
Total revenue
OPERATING EXPENSES
General & administrative	3,526,863	2,000,937	7,345,295
Research & development	824,336	516,798	2,365,539
Total Operating Expenses	4,351,199	2,517,735	9,710,834
OTHER EXPENSES (INCOME)
Interest income	(82)	(596)	(678)
Accretion expense	829,969	1,500	831,469
Deferred financing costs amortization	14,159		14,159
Interest expense	137,098	1,940	139,038
Loss on extinguishment of debt	32,853		32,853
Total Other Expenses (Income)	1,013,997	2,844	1,016,841
NET LOSS	$ (5,365,196)	$ (2,520,579)	$ (10,727,675)
Net loss per share, basic and diluted	$ (0.25)	$ (0.12)
Weighted average of shares outstanding	21,169,091	20,882,199